Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evan Appelbaum

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
The American Journal of Cardiology|February 7, 2009
Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosisFrederick L Ruberg, Evan Appelbaum, Ravin Davidoff, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 15, 2012
Influence of diabetes on efficacy of aliskiren, losartan or both on left ventricular mass regressionOrly Vardeny, Anne-Catherine Pouleur, Madoka Takeuchi, et al.
Radiology|November 4, 2010
Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imagingCaitlin J Harrigan, Dana C Peters, C Michael Gibson, et al.
JACC. Cardiovascular Imaging|August 15, 2009
Noncardiac pathology on clinical cardiac magnetic resonance imagingPeter G Chan, Martin P Smith, Thomas H Hauser, et al.
Circulation|January 21, 2009
Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophyScott D Solomon, Evan Appelbaum, Warren J Manning, et al.
Circulation|December 22, 2010
Autologous cardiomyotissue implantation promotes myocardial regeneration, decreases infarct size, and improves left ventricular functionJoanna J Wykrzykowska, Audrey Rosinberg, Seung U Lee, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 13, 2011
Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertensionAnne-Catherine Pouleur, Hajime Uno, Margaret F Prescott, et al.
Clinical Cardiology|November 26, 2004
The incremental value of troponin-I testing in patients with intermediate risk unstable anginaEvan Appelbaum, M Urooj Zafar, H C Glick, et al.
American Heart Journal|June 23, 2009
Association of Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade with cardiovascular magnetic resonance measures of infarct architecture after primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionEvan Appelbaum, JoEllyn M Abraham, Yuri B Pride, et al.
Journal of Thrombosis and Thrombolysis|February 5, 2008
Association of TIMI myocardial perfusion grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarctionEvan Appelbaum, Ajay J Kirtane, Alicia Clark, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
The American Journal of Cardiology|February 7, 2009
Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosisFrederick L Ruberg, Evan Appelbaum, Ravin Davidoff, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 15, 2012
Influence of diabetes on efficacy of aliskiren, losartan or both on left ventricular mass regressionOrly Vardeny, Anne-Catherine Pouleur, Madoka Takeuchi, et al.
Radiology|November 4, 2010
Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imagingCaitlin J Harrigan, Dana C Peters, C Michael Gibson, et al.
JACC. Cardiovascular Imaging|August 15, 2009
Noncardiac pathology on clinical cardiac magnetic resonance imagingPeter G Chan, Martin P Smith, Thomas H Hauser, et al.
Circulation|January 21, 2009
Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophyScott D Solomon, Evan Appelbaum, Warren J Manning, et al.
Circulation|December 22, 2010
Autologous cardiomyotissue implantation promotes myocardial regeneration, decreases infarct size, and improves left ventricular functionJoanna J Wykrzykowska, Audrey Rosinberg, Seung U Lee, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 13, 2011
Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertensionAnne-Catherine Pouleur, Hajime Uno, Margaret F Prescott, et al.
Clinical Cardiology|November 26, 2004
The incremental value of troponin-I testing in patients with intermediate risk unstable anginaEvan Appelbaum, M Urooj Zafar, H C Glick, et al.
American Heart Journal|June 23, 2009
Association of Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade with cardiovascular magnetic resonance measures of infarct architecture after primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionEvan Appelbaum, JoEllyn M Abraham, Yuri B Pride, et al.
Journal of Thrombosis and Thrombolysis|February 5, 2008
Association of TIMI myocardial perfusion grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarctionEvan Appelbaum, Ajay J Kirtane, Alicia Clark, et al.
Pageof 6